HealthTech Bioactives Partners with Abolis for Sustainable Production of High-Value Polyphenols
PARIS, May 14, 2024 /PRNewswire/ — HealthTech Bioactives (HTBA) has chosen Abolis as their partner to develop strains to produce valuable polyphenols, addressing supply chain challenges and driving innovation in the industry. Founded in 2019, after 40 years’ experience under different ownership, HTBA is a leading global producer of innovative health solutions. With a portfolio of […]